Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 2 min ago
PreprintAll rights reservedmedRxiv

Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy

  1. 1Fingerprint Diagnostics

Related

  1. Beyond Sulfation: Integrated Immunohistochemical, Genomic, and Proteomic Profiling Identifies PAPSS1 as a Potential Regulator of Breast Cancer Progression.
    Rabab Ahmed Ahmed Mohammed, Amina Ismaeel, Safa Alshaikh +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Integrated multi-omics profiling identifies ECM-associated and systemic metabolic alterations associated with osteosarcoma metastasis
    Ning Liu, Juan Wang, Yan Lai +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  3. Urinary DNA Methylation Profiling Identifies a Biologically Distinct Subgroup of Low-Grade Urothelial Carcinoma with High-Grade-Associated Features
    Marc Andreu-Inglés, Alina-Iuliana Onoiu, Marc Grifoll-Escoda +6
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMC
  4. Deep Learning-Based Spatial Profiling Identifies MET-Associated Immune Exclusion and Therapeutic Vulnerability Underlying Racial Disparities in Head and Neck Cancer
    Xinyu Cui, Fanghui Chen, Ashley McCook-Veal +7
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxivPMC
  5. Integrated RNA-Seq Profiling Identifies NRXN1+ Cell-Fibroblast Associated MAPK Signaling in Prurigo Nodularis.
    Jiyun Jang, Young-Bok Lee, Hwee-Seon Park +5
    Allergy, asthma & immunology researchPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@misc{bukovec2026cancer,
  title = {{Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy}},
  author = {D. Bukovec and M. Gjorgjievska and S. Kocevska and M. Nikolova and L. Mirkovikj and I. Kungulovski and Z. Mitrev and G. Kungulovski},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.15.26363151},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.15.26363151v1},
}
RIS
TY  - UNPB
TI  - Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
AU  - D. Bukovec
AU  - M. Gjorgjievska
AU  - S. Kocevska
AU  - M. Nikolova
AU  - L. Mirkovikj
AU  - I. Kungulovski
AU  - Z. Mitrev
AU  - G. Kungulovski
PY  - 2026
DA  - 2026/09/15
PB  - medRxiv
DO  - 10.64898/2026.09.15.26363151
UR  - https://www.medrxiv.org/content/10.64898/2026.09.15.26363151v1
ER  -